Agency
National Institute of Health (NIH)
Institute
Office of The Director, NCI (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CO074102-056
Application #
2304276
Study Section
Project Start
1987-09-26
Project End
1994-09-25
Budget Start
1992-09-23
Budget End
1993-03-05
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Program Resources, Inc.
Department
Type
DUNS #
City
Reston
State
VA
Country
United States
Zip Code
Asojo, Oluwatoyin A; Gulnik, Sergei V; Afonina, Elena et al. (2003) Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum. J Mol Biol 327:173-81
Asojo, Oluwatoyin A; Afonina, Elena; Gulnik, Sergei V et al. (2002) Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 A in complex with the inhibitors rs367 and rs370. Acta Crystallogr D Biol Crystallogr 58:2001-8
Lunn, G; Phillips, L R; Pacula-Cox, C (1998) Reversed-phase high-performance liquid chromatography of 4-(2-pyridyl)-1-piperazinethiocarboxylic acid 2-[1-(pyridyl)ethylidene]hydrazide dihydrochloride (NSC 348977), a synthetic thiosemicarbazone with antitumor activity. J Chromatogr B Biomed Sci Appl 708:217-22
Mehta, R R; Graves, J M; Shilkaitis, A et al. (1998) Development of a new metastatic human breast carcinoma xenograft line. Br J Cancer 77:595-604
Silva, A M; Lee, A Y; Erickson, J W et al. (1998) Structural analysis of plasmepsin II. A comparison with human aspartic proteases. Adv Exp Med Biol 436:363-73
Mehta, R R; Hawthorne, M E; Graves, J M et al. (1998) Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells. Eur J Cancer 34:902-7
Shiao, Y H; Buzard, G S; Weghorst, C M et al. (1997) DNA template as a source of artifact in the detection of p53 gene mutations using archived tissue. Biotechniques 22:608-10, 612
Chertov, O; Michiel, D F; Xu, L et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271:2935-40
Curti, B D; Ochoa, A C; Urba, W J et al. (1996) Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients. J Immunother Emphasis Tumor Immunol 19:296-308
Siders, W M; Halloran, P J; Fenton, R G (1996) Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells. Cancer Res 56:5638-46

Showing the most recent 10 out of 567 publications